In recent times there has been much talk about the imminent
collapse of the liberal rules based order with Russia and China citied as the main culprits for this destabilisation. Combine this with COVID-19 pandemic and, as Dr Bobo Lo argues, nations have regressed into narrow self-interest . He believes that the real issue is a collective Western failure to live up to the principles of liberalism, a failure exacerbated by gross policy misjudgements and fraying transatlantic and European unity . How do we move forward form here?
Then, (at 15 mins), how did people in Ancient Greece cope with sickness and disease?Dr Meghan Henning explains that they viewed the city as a body. If a city had suffered a disaster, such as famine and plague, like the body, it needed to be purged or cleansed with blood or fire . The way to purify the polis was a ritual known as the pharmakos . In short, this meant that often two people were expelled from the city and often killed. It was thought that
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington s disease
Alchemab using unique approach to explore adaptive immunity identifying naturally protective antibodies in resilient patients to specific diseases
Innovate UK Grant to support the finding of a disease-modifying therapy for Huntington s disease (HD), a degenerative disease with no cure and no therapies to prevent progression
Alchemab is working in collaboration with Medicines Discovery Catapult, a not-for-profit, government-funded organisation supporting UK life science innovators
HD samples being supplied by CHDI Foundation
Alchemab, a biotech company developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, has been awarded a UK Biomedical Catalyst early award grant from Innovate UK to support the development of a novel disease-modifying antibody therapy for Huntington s disease (HD). The grant
Non-invasive skin swab samples enough to detect Covid infection: Study
March 16, 2021
Currently, most popular approach to detect Covid is through RT-PCR test
Researchers at the University of Surrey found after carrying out a study that non-invasive skin swab samples are enough to detect Covid-19 infection.
Currently, the most popular approach to detect Covid-19 is through the RT-PCR test, which involves taking a swab of the back of the throat and far inside the nose.
The study, published in the
Lancet E Clinical Medicine, was carried out by chemists from Surrey who collaborated with Frimley NHS Trust and the Universities of Manchester and Leicester.
(ASX:IMM), an Australian biotechnology company developing novel immunotherapy treatments for cancer, infectious disease and autoimmune disease, has announced a second clinical trial collaboration and supply agreement with MSD.
The new collaboration will involve a new Phase 2b clinical trial of Immutep’s eftilagimod alpha (efti or IMP321) in combination with MSD’s KEYTRUDA (pembrolizumab).
The trial, which is called TACTI-003 (Two Active Immunotherapies), will test the combination as a first-line treatment of patients with head and neck squamous cell carcinoma (HNSCC), compared to KEYTRUDA alone. The trial will involve approximately 160 patients and take place in sites in the US, Australia and Europe. The first patient is expected to be enrolled in mid-2021.